Status:

COMPLETED

We Compared the Covid-19 Acute Respiratory Distress Syndrome (ARDS) Patients Who Applied Prone Positioning for16-24 Hours vs 24-48 Hours

Lead Sponsor:

Bakirkoy Dr. Sadi Konuk Research and Training Hospital

Conditions:

Morality

Oxygenation Indices

Eligibility:

All Genders

18+ years

Brief Summary

The goal of this study is to understand if there is any improvement on oxygenation of patients diagnosed with Covid-19 ARDS patients when we extend the duration of prone positioning. Second outcome o...

Eligibility Criteria

Inclusion

  • COVİD 19 ARDS patients patients who have been intubated for 48 hours and more

Exclusion

  • Pediatric patients Patients who extubated in less than 48 hours Patients with Lung and pleural malignancies

Key Trial Info

Start Date :

October 3 2022

Trial Type :

OBSERVATIONAL

Allocation :

ACTUAL

End Date :

February 15 2024

Estimated Enrollment :

350 Patients enrolled

Trial Details

Trial ID

NCT06530095

Start Date

October 3 2022

End Date

February 15 2024

Last Update

July 31 2024

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Bakirkoy Dr Sadi konuk Research and Training hospital

Istanbul, Turkey (Türkiye), 34450

We Compared the Covid-19 Acute Respiratory Distress Syndrome (ARDS) Patients Who Applied Prone Positioning for16-24 Hours vs 24-48 Hours | DecenTrialz